InvestorsHub Logo
Followers 105
Posts 14144
Boards Moderated 1
Alias Born 01/07/2010

Re: Aggie14 post# 19049

Tuesday, 05/09/2017 7:44:22 AM

Tuesday, May 09, 2017 7:44:22 AM

Post# of 346678
Uplist expectations

Based on what they said in the PR their goal is to complete the audits for y/e 2015, 2016 and 2017 before they uplist and file Form 10. My guess is August if that is the case. Unless that has changed. But keep in mind they are very busy right now with build out of 3rd Snakes location and also everything else going on with Snakes and Grozone. Timing the uplist basically the same time as the 3rd location opening might just be excellent timing.

From the March 29 PR:
"Since the recent acquisition of Snakes & Lagers Inc. / Snakes & Lattes Inc. and the resultant impact on the financial statements, the company intends to up-list from the OTC Pink tier. On May 12th 2015, the company filed audited financial statements completed by MNP LLC. for the fiscal year ends of 2013 and 2014. Since inception in 1985 Amfil Technologies Inc. had always been an SEC reporting issuer until our switch to alternative reporting in May 2015. The 2015, 2016 and the quarterly financial statements thus far into 2017 were filed unaudited through OTC Markets directly as per the alternative reporting guidelines. Over the coming months, the company intends to have year ends 2015, 2016 and 2017 audited in conjunction with the filing of a Form 10 to re-register as a fully reporting company with the Securities & Exchange Commission. We would like to time this process if possible with our fiscal year end 2017, being June 30th 2017 or shortly thereafter.

The effect of this would be an immediate up-listing from OTC Pink to the OTCQB tier. The up-listing to the OTCQB is an activity we have considered for some time. The current plans to up list Amfil initially to the OTCQB tier will provide the investment community with full transparency and allow the stock to be quoted and traded by a wider range of brokerages, particularly retail brokers, eliminating many of the challenges we endure as an OTC Pink Current company. We will have more to discuss about other aspects of this up-list registration in the coming weeks."